NDC 50881-013 – Monjuvi
Tafasitamab 200 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous
Product NDC50881-013
Product details
- Brand name
- Monjuvi
- Generic name
- Tafasitamab-cxix
- Labeler
- Incyte Corporation
- Dosage form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Marketing category
- BLA · BLA761163
- Marketed since
- August 5, 2020
- Listing expires
- December 31, 2026
Active ingredients
- Tafasitamab 200 mg/5mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 50881-013-03 | 1 VIAL in 1 CARTON (50881-013-03) / 5 mL in 1 VIAL | Aug 5, 2020 |
Other Monjuvi products
- 73535-208 Tafasitamab 200 mg/5mL · Injection, Powder, Lyophilized, For Solution · Incyte Corporation